Roberto De Ponti

Roberto De Ponti

Head of Corporate New Ventures and Strategic Investments | Helsinn Investment Fund

Dr. De Ponti, a Pharmacist by training and an EU Qualified Person, is Head of Corporate New Ventures and Strategic Investments for Helsinn International Services, the advisor company to the new Helsinn Investment Fund, part of the Helsinn Group. The new Helsinn fund aims to complement and expand the presence of Helsinn in early stage companies, contributing to the progression of new drugs, medical devices and diagnostics mainly in oncology therapeutics, oncology supportive care, metabolism and gastro-intestinal areas.

From 2008 to when he joined the new fund in 2016, Dr. De Ponti was Head of Corporate Business Development at Helsinn where his responsibilities included identifying external research projects, in-licensing, new investments and setting up strategic collaborations with companies and Universities.

Prior joining the Helsinn Group, Dr. De Ponti held responsibilities for in and out-licensing for Indena, a leading natural derivatives company with pharmaceutical products fighting cancer. Before that he served as Site Lead and Head of Pharmaceutical Sciences in the Oncology Italian site of Pharmacia and Pfizer which was eventually spun-off and where he brought the Pharma Science business unit to breakeven. Dr. De Ponti has held several patents covering the development and the commercialization of oncology drugs.

Find me at these events

Corporate venture capitals

12/11/2019 | 15:05 - 15:25

Scroll to top